Last Price Today's Change   Day's Range   Trading Volume
1.34   -0.05 (3.60%)  1.34 - 1.39  20,262


Avg Volume (4 weeks):5,581
4 Weeks Range:1.34 - 1.50
4 Weeks Price Volatility (%):
52 Weeks Range:0.89 - 1.505
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Cyclopharm Limited is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. The Company operates in two business segments: Technegas segment and Molecular imaging segment. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment produces radiopharmaceuticals used by physicians in the detection of cancer, neurological disorders and cardiac diseases. The Company offers Technegas for lung imaging, and Molecular Imaging/Positron Emission Tomography radiopharmaceuticals, which are used in cancer, brain and cardiac imaging. The Company formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Company's Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.

  Be the first to like this.


573  587  667  9342 

Top 10 Active Counters
 SPO 1.69+0.06 
 GOR 1.305-0.27 
 VPR 0.0010.00 
 SYT 0.0020.00 
 BNL 0.01+0.004 
 CGB 0.029-0.008 
 MSE 0.02+0.002 
 FRN 0.023+0.003 
 ADN 0.061-0.002 
 BPH 0.001-0.001 
Partners & Brokers